Trojano, M <br/><br/>
The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy.  [electronic resource] 

 -  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology  Dec 2005 
 - S179-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1590-1874 
<br/><br/><label>Standard No.: </label>10.1007/s10072-005-0511-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Cohort Studies<br/>Disability Evaluation<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Interferon beta-1a<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Italy<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--drug therapy<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Population Surveillance<br/>Product Surveillance, Postmarketing<br/>Prospective Studies<br/>Secondary Prevention<br/>Treatment Outcome